Updated Experience With Inolimomab as Treatment for Corticosteroid-Refractory Acute Graft-Versus-Host Disease

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2012.11.012
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Ruxolitinib as a Promising Treatment for Corticosteroid-Refractory Graft-Versus -Host Disease

British Journal of Haematology
Hematology
2017English

Sirolimus for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease

Bone Marrow Transplantation
TransplantationHematology
2009English

Tocilizumab for Steroid Refractory Acute Graft-Versus-Host Disease

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2015English

Etanercept as Treatment of Steroid-Refractory Acute Graft Versus Host Disease in Pediatric Patients

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Experience With the Use of Infliximab and/or Extracorporeal Photopheresis in Steroid-Refractory Acute Graft Versus Host Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Topical Corticosteroid Therapy for Cicatricial Conjunctivitis Associated With Chronic Graft-Versus-Host Disease

Bone Marrow Transplantation
TransplantationHematology
2004English

Treatment of Refractory Dry Eye Associated With Graft Versus Host Disease With 0.03% Tacrolimus Eyedrops

Journal of Ocular Pharmacology and Therapeutics
OphthalmologyPharmacology
2013English

Outcomes of Infliximab in Management of Steroid-Refractory Acute Graft Versus Host Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Treatment of Steroid-Resistant Acute Graft-Versus-Host Disease With Daclizumab and Etanercept

Bone Marrow Transplantation
TransplantationHematology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy